Acquisitions (Tables)

12 Months Ended

Sep. 30, 2015

Asset Acquisition [Abstract]

Summary of Estimated Relative Fair Values at Date of Acquisition

The following table summarizes the estimated relative fair values of the assets acquired at the date of acquisition:

Intangible assets - patents	$	21,728,334
Intangible assets – license		3,128,880
Acquired in-process research and development - Pre-Clinical Candidates		10,142,786
Total purchase consideration	$	35,000,000

Summary of Purchase Consideration

The purchase consideration was composed of the following:

Cash Paid	$	10,000,000
Value of Shares Issued		25,000,000
Total purchase consideration	$	35,000,000